1. Home
  2. VNRX vs PTLE Comparison

VNRX vs PTLE Comparison

Compare VNRX & PTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • PTLE
  • Stock Information
  • Founded
  • VNRX N/A
  • PTLE 2013
  • Country
  • VNRX United States
  • PTLE Singapore
  • Employees
  • VNRX N/A
  • PTLE N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PTLE Oil Refining/Marketing
  • Sector
  • VNRX Health Care
  • PTLE Energy
  • Exchange
  • VNRX Nasdaq
  • PTLE Nasdaq
  • Market Cap
  • VNRX 67.2M
  • PTLE 56.3M
  • IPO Year
  • VNRX N/A
  • PTLE 2024
  • Fundamental
  • Price
  • VNRX $0.66
  • PTLE $8.95
  • Analyst Decision
  • VNRX Strong Buy
  • PTLE
  • Analyst Count
  • VNRX 4
  • PTLE 0
  • Target Price
  • VNRX $4.17
  • PTLE N/A
  • AVG Volume (30 Days)
  • VNRX 577.3K
  • PTLE 1.0M
  • Earning Date
  • VNRX 11-14-2024
  • PTLE 12-31-2024
  • Dividend Yield
  • VNRX N/A
  • PTLE N/A
  • EPS Growth
  • VNRX N/A
  • PTLE N/A
  • EPS
  • VNRX N/A
  • PTLE 0.08
  • Revenue
  • VNRX $1,285,827.00
  • PTLE $102,106,509.00
  • Revenue This Year
  • VNRX $180.66
  • PTLE N/A
  • Revenue Next Year
  • VNRX $558.69
  • PTLE N/A
  • P/E Ratio
  • VNRX N/A
  • PTLE $101.31
  • Revenue Growth
  • VNRX 97.50
  • PTLE 36.47
  • 52 Week Low
  • VNRX $0.43
  • PTLE $2.01
  • 52 Week High
  • VNRX $1.23
  • PTLE $10.19
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 52.35
  • PTLE N/A
  • Support Level
  • VNRX $0.57
  • PTLE N/A
  • Resistance Level
  • VNRX $0.68
  • PTLE N/A
  • Average True Range (ATR)
  • VNRX 0.08
  • PTLE 0.00
  • MACD
  • VNRX 0.00
  • PTLE 0.00
  • Stochastic Oscillator
  • VNRX 82.35
  • PTLE 0.00

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

Share on Social Networks: